【DPHARMA 7148 交流专区】（前名 CCMDBIO）

xiaomao

最近好像感冒咳嗽肆虐马来西亚和新加坡。
走到那里都看到生病的人。
而周围的人好像都生病。。。
药剂业是不是会有好消息呢？？

icy97

SUMMARY OF KEY FINANCIAL INFORMATION

31/03/2012

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		31/03/2012	31/03/2011	31/03/2012	31/03/2011
		$$'000	$$'000	$$'000	$$'000
1	Revenue	36,057	32,984	36,057	32,984
2	Profit/(loss) before tax	8,869	7,875	8,869	7,875
3	Profit/(loss) for the period	6,708	5,924	6,708	5,924
4	Profit/(loss) attributable to ordinary equity holders of the parent	6,708	5,924	6,708	5,924
5	Basic earnings/(loss) per share (Subunit)	4.83	4.27	4.83	4.27
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	1.2300		1.1800

icy97

CENTURY BOND BHD

12/07/2012 05:14:06 PM

Type	Announcement
Subject	OTHERS
Description	PROPOSED FINAL TAX-EXEMPT DIVIDEND OF 2.5 SEN PER SHARE IN RESPECT OF THE FINANCIAL YEAR ENDED 31 MARCH 2012
Century Bond Bhd is pleased to announce that the Board of Directors proposes a final tax-exempt dividend of 2.5 sen per share in respect of the financial year ended 31 March 2012 which is subject to shareholders' approval at the forthcoming 20th Annual General Meeting. The entitlement date and payment date for the proposed final dividend will be determined at a later date.

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 30/06/2012

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		30/06/2012	30/06/2011	30/06/2012	30/06/2011
		$$'000	$$'000	$$'000	$$'000

1	Revenue	34,355	35,345	70,412	68,329
2	Profit/(loss) before tax	9,037	9,292	17,906	17,166
3	Profit/(loss) for the period	6,867	6,932	13,575	12,856
4	Profit/(loss) attributable to ordinary equity holders of the parent	6,867	6,932	13,575	12,856
5	Basic earnings/(loss) per share (Subunit)	4.95	4.99	9.78	9.26
6	Proposed/Declared dividend per share (Subunit)	3.50	3.50	3.50	3.50
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	1.1700		1.1800

icy97

CCM DUOPHARMA BIOTECH BERHAD

16/08/2012 05:03:05 PM

EX-date	15/10/2012
Entitlement date	17/10/2012
Entitlement time	04:00:00 PM
Entitlement subject	Interim Dividend
Entitlement description	Interim Tax-Exempt Dividend of 3.5 sen per ordinary share of RM0.50 each for the financial year ending 31 December 2012.
Period of interest payment	to
Financial Year End	31/12/2012
Share transfer book & register of members will be	to closed from (both dates inclusive) for the purpose of determining the entitlements
Registrar's name ,address, telephone no	Tricor Investor Services Sdn Bhd Level 17, The Gardens North Tower Mid Valley City, Lingkaran Syed Putra 59200 Kuala Lumpur Telephone No.: 03-2264 3883 Facsimile No.: 03-2282 1886
Payment date	09/11/2012
a.Securities transferred into the Depositor's Securities Account before 4:00 pm in respect of transfers	17/10/2012
b.Securities deposited into the Depositor's Securities Account before 12:30 pm in respect of securities exempted from mandatory deposit
c. Securities bought on the Exchange on a cum entitlement basis according to the Rules of the Exchange.
Number of new shares/securities issued (units) (If applicable)
Entitlement indicator	Currency
Currency	Malaysian Ringgit (MYR)
Entitlement in Currency	0.035

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 30/09/2012

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		30/09/2012	30/09/2011	30/09/2012	30/09/2011
		$$'000	$$'000	$$'000	$$'000

1	Revenue	29,521	36,767	99,932	105,096
2	Profit/(loss) before tax	8,392	9,726	26,298	26,892
3	Profit/(loss) for the period	6,442	7,521	20,017	20,377
4	Profit/(loss) attributable to ordinary equity holders of the parent	6,442	7,521	20,017	20,377
5	Basic earnings/(loss) per share (Subunit)	4.64	5.42	14.42	14.68
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	1.2100		1.1800

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 31/12/2012

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		31/12/2012	31/12/2011	31/12/2012	31/12/2011
		$$'000	$$'000	$$'000	$$'000

1	Revenue	35,378	33,036	135,310	138,132
2	Profit/(loss) before tax	9,000	7,836	35,298	34,728
3	Profit/(loss) for the period	5,997	6,329	26,014	26,705
4	Profit/(loss) attributable to ordinary equity holders of the parent	5,997	6,329	26,014	26,705
5	Basic earnings/(loss) per share (Subunit)	4.32	4.56	18.74	19.24
6	Proposed/Declared dividend per share (Subunit)	10.50	9.70	14.00	11.26
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	1.2200		1.1800

icy97

CCM DUOPHARMA BIOTECH BERHAD

EX-date	14/06/2013
Entitlement date	18/06/2013
Entitlement time	04:00:00 PM
Entitlement subject	Final Dividend
Entitlement description	Final dividend of 10.5 sen per ordinary share, tax exempt under the single-tier tax system
Period of interest payment	to
Financial Year End	31/12/2012
Share transfer book & register of members will be	to closed from (both dates inclusive) for the purpose of determining the entitlements
Registrar's name ,address, telephone no	Tricor Investor Services Sdn Bhd Level 17, The Gardens North Tower Mid Valley City, Lingkaran Syed Putra 59200 Kuala Lumpur Telephone no: 03-2264 3883
Payment date	12/07/2013
a.Securities transferred into the Depositor's Securities Account before 4:00 pm in respect of transfers	18/06/2013
b.Securities deposited into the Depositor's Securities Account before 12:30 pm in respect of securities exempted from mandatory deposit
c. Securities bought on the Exchange on a cum entitlement basis according to the Rules of the Exchange.
Number of new shares/securities issued (units) (If applicable)
Entitlement indicator	Currency
Currency	Malaysian Ringgit (MYR)
Entitlement in Currency	0.105

Remarks :

The Final Dividend is subject to shareholders' approval at the forthcoming Annual General Meeting.

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 31/03/2013

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		31/03/2013	31/03/2012	31/03/2013	31/03/2012
		$$'000	$$'000	$$'000	$$'000

1	Revenue	37,837	36,057	37,837	36,057
2	Profit/(loss) before tax	8,956	8,869	8,956	8,869
3	Profit/(loss) for the period	6,699	6,708	6,699	6,708
4	Profit/(loss) attributable to ordinary equity holders of the parent	6,699	6,708	6,699	6,708
5	Basic earnings/(loss) per share (Subunit)	4.83	4.83	4.83	4.83
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	1.2700		1.2200

icy97

馬化學藥業將聯營併購

大馬  2013-06-14 10:34
（吉隆坡13日訊）馬化學藥業（CCMDBIO，7148，主板消費品組）首席執行員李奧納阿里夫說，馬化學藥業將積極開拓東盟市場，並放眼海外市場取得雙位數業務成長。

他指出，基於東盟各國對藥業法規的鬆緊各異，為了克服進軍區域市場的各項障礙，決定透過聯營（持有多數股）、併購方式擴展業務。

他今日在股東大會上後指出，海外市場只佔營業額的很小比重，因而成長空間非常大，藉此擴展有望取得較上財政年更佳業績。

看中印菲越人口龐大

公司首席財務員祝武光披露，海外市場約佔營業額8%，或2013年營業額的8%，或相等於1千100萬令吉。

李奧納說，未來將專注開發印尼、菲律賓與越南市場，主要是其人口龐大，也考慮進軍中東，不過中東市場還在起步階段。

他說，公司藥業產品出口市場主要在新加坡與泰國，新加坡藥業法規環境幾乎與大馬相同，因而容易進入市場，泰國的也還順利，全球總共出口至20多個國家。

他指出，印尼市場目前也已委任一名國家主管派駐印尼，越南則設有代辦事處及委任經銷商。

他說，藥業的營運環境非常具競爭性，有時也面臨各國的保護主義，目前主要面臨中國、印度、巴基斯坦等學名藥的競爭，因而必須加強國際競爭力，長遠才能生存。

“為確保有足夠競爭力，每年也撥出營業額的2%，作為研發用途。”

他說，除此，公司未來的其餘兩項策略，還包括與跨國公司探討腫瘤臨床療效和為腎衰竭病人展開紅血球生成素（EPO）臨床實驗、在清真藥劑居領導地位。

該公司去年在美國波斯頓舉行的生物國際大會上，與韓國公司Pangen Biotech公司簽署協議，以對末期腎衰竭病人展開類似臨床實驗。

另外，他指出，在腫瘤臨床療效與跨國公司合作，主要是配合政府鼓勵更多合伙計劃的意願，以開發這方面的無限潛能，他也相信這只是其生產仿製業的一個起步。

全球生物仿製業市場在2011年上半年的市值達3億7千800萬美元（約11億7千200萬令吉），預料可在2015年增至19億至26億美元（約58億9千萬至80億6千萬令吉）。（星洲日報／財經）

lcchong76

CCMDBIO – Q1 2013 季度报告 (http://www.bursamalaysia.com/mar ... nouncements/1298933) (27 May 2013)

我的分析 – http://lcchong.files.wordpress.com/2013/08/ccmdbio-q1-2013.pdf or more (http://lcchong.wordpress.com/knowledge-sharing/)

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 30/06/2013

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		30/06/2013	30/06/2012	30/06/2013	30/06/2012
		$$'000	$$'000	$$'000	$$'000

1	Revenue	37,988	34,355	75,826	70,412
2	Profit/(loss) before tax	13,007	9,037	21,963	17,906
3	Profit/(loss) for the period	10,689	6,867	17,388	13,575
4	Profit/(loss) attributable to ordinary equity holders of the parent	10,689	6,867	17,388	13,575
5	Basic earnings/(loss) per share (Subunit)	7.70	4.95	12.53	9.78
6	Proposed/Declared dividend per share (Subunit)	4.00	3.50	4.00	3.50
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	1.3500		1.2200

icy97

CCM DUOPHARMA BIOTECH BERHAD

EX-date	14/10/2013
Entitlement date	17/10/2013
Entitlement time	04:00:00 PM
Entitlement subject	Interim Dividend
Entitlement description	Interim Single Tier Dividend of 4 sen per ordinary share
Period of interest payment	to
Financial Year End	31/12/2013
Share transfer book & register of members will be	to closed from (both dates inclusive) for the purpose of determining the entitlements
Registrar's name ,address, telephone no	Tricor Investor Services Sdn Bhd Level 17, The Gardens North Tower Mid Valley City, Lingkaran Syed Putra 59200 Kuala Lumpur Telephone no.: 03-2264 3883
Payment date	08/11/2013
a.Securities transferred into the Depositor's Securities Account before 4:00 pm in respect of transfers	17/10/2013
b.Securities deposited into the Depositor's Securities Account before 12:30 pm in respect of securities exempted from mandatory deposit
c. Securities bought on the Exchange on a cum entitlement basis according to the Rules of the Exchange.
Number of new shares/securities issued (units) (If applicable)
Entitlement indicator	Currency
Currency	Malaysian Ringgit (MYR)
Entitlement in Currency	0.04

lcchong76

CCMDBIO – Q2 2013 季度报告 (http://www.bursamalaysia.com/mar ... nouncements/1390741) on 28 Aug 2013

我的分析 – http://lcchong.wordpress.com/201 ... alysis-29-aug-2013/ or http://lcchong.wordpress.com/knowledge-sharing/

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 30/09/2013

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		30/09/2013	30/09/2012	30/09/2013	30/09/2012
		$$'000	$$'000	$$'000	$$'000

1	Revenue	40,845	29,521	116,671	99,932
2	Profit/(loss) before tax	9,054	8,391	31,017	26,298
3	Profit/(loss) for the period	6,786	6,442	24,175	20,017
4	Profit/(loss) attributable to ordinary equity holders of the parent	6,786	6,442	24,175	20,017
5	Basic earnings/(loss) per share (Subunit)	4.89	4.64	17.41	14.42
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	1.2900		1.2200

icy97

馬化工聯藥 淨利漲55%

企業財經26 Feb 2014 23:00
（吉隆坡26日訊）私人醫院和政府醫院業務收入推動，馬化工聯藥（CCMDBIO，7148，主要板消費）上財年截至12月底末季，營業額按年上漲29%至4573萬令吉，淨利大漲55%至931萬令吉，每股派息13.5仙。

該公司全年營業額按年增長20%至1億6241萬令吉，淨利揚14%至3228萬令吉，全年股息17.5仙。

馬化工聯藥指出，公司的私人醫院和政府醫院業務收入增長顯著，推動公司營業額成長，但稅前盈利未隨營業額漲幅增加。

儘管未來全球經濟不穩定，但該公司預計醫療行業依然能穩健成長。【中国报财经】

SUMMARY OF KEY FINANCIAL INFORMATION 31/12/2013

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		31/12/2013	31/12/2012	31/12/2013	31/12/2012
		$$'000	$$'000	$$'000	$$'000

1	Revenue	45,734	35,378	162,405	135,310
2	Profit/(loss) before tax	9,160	9,000	40,175	35,298
3	Profit/(loss) for the period	9,313	5,998	32,275	26,014
4	Profit/(loss) attributable to ordinary equity holders of the parent	9,313	5,998	32,275	26,014
5	Basic earnings/(loss) per share (Subunit)	6.71	4.32	23.25	18.74
6	Proposed/Declared dividend per share (Subunit)	13.50	10.50	17.50	14.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	1.3100		1.2200

icy97

CCM DUOPHARMA BIOTECH BERHAD

EX-date	22/05/2014
Entitlement date	26/05/2014
Entitlement time	04:00:00 PM
Entitlement subject	Final Dividend
Entitlement description	Final Dividend of 13.5 sen per ordinary share, tax exempt dividend under the single-tier system
Period of interest payment	to
Financial Year End
Share transfer book & register of members will be	to closed from (both dates inclusive) for the purpose of determining the entitlements
Registrar's name ,address, telephone no	Tricor Investor Services Sdn Bhd Level 17, The Gardens North Tower Mid Valley City, Lingkaran Syed Putra 59200 Kuala Lumpur Telephone no.: 03-2264 3883
Payment date	20/06/2014
a.Securities transferred into the Depositor's Securities Account before 4:00 pm in respect of transfers	26/05/2014
b.Securities deposited into the Depositor's Securities Account before 12:30 pm in respect of securities exempted from mandatory deposit
c. Securities bought on the Exchange on a cum entitlement basis according to the Rules of the Exchange.
Number of new shares/securities issued (units) (If applicable)
Entitlement indicator	Currency
Currency	Malaysian Ringgit (MYR)
Entitlement in Currency	0.135

icy97

马化工药业净利增25%

财经新闻 财经  2014-05-21 12:20
（吉隆坡20日讯）马化工药业（CCMDBIO，7148，主板消费产品股）截至3月杪首季净利年增25%，至836万5000令吉，相等于每股盈利6.03仙。

上财年同期净利为669万9000令吉。

首季营业额则按年增长7%至4049万5000令吉，上财年同期为3783万7000令吉。

另一方面，马化工药业总执行长伦纳德阿立夫在股东大会后向媒体表示，放眼每年推出5项新产品，以巩固业绩增长策略。

目前，公司每年推出2项新产品。【南洋网财经】

SUMMARY OF KEY FINANCIAL INFORMATION 31/03/2014

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		31/03/2014	31/03/2013	31/03/2014	31/03/2013
		$$'000	$$'000	$$'000	$$'000

1	Revenue	40,495	37,837	40,495	37,837
2	Profit/(loss) before tax	11,175	8,956	11,175	8,956
3	Profit/(loss) for the period	8,365	6,699	8,365	6,699
4	Profit/(loss) attributable to ordinary equity holders of the parent	8,365	6,699	8,365	6,699
5	Basic earnings/(loss) per share (Subunit)	6.03	4.83	6.03	4.83
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	1.3700		1.3100

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 30/06/2014

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		30/06/2014	30/06/2013	30/06/2014	30/06/2013
		$$'000	$$'000	$$'000	$$'00

1	Revenue	40,623	37,988	81,118	75,826
2	Profit/(loss) before tax	10,107	13,007	21,302	21,963
3	Profit/(loss) for the period	7,513	10,689	15,892	17,388
4	Profit/(loss) attributable to ordinary equity holders of the parent	7,513	10,689	15,892	17,388
5	Basic earnings/(loss) per share (Subunit)	5.41	7.70	11.45	12.53
6	Proposed/Declared dividend per share (Subunit)	4.00	4.00	4.00	4.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	1.2900		1.3100

icy97

EX-date	15/10/2014
Entitlement date	17/10/2014
Entitlement time	04:00:00 PM
Entitlement subject	Interim Dividend
Entitlement description	Interim Single Tier Dividend of 4 sen per ordinary share
Period of interest payment	to
Financial Year End	31/12/2014
Share transfer book & register of members will be	to closed from (both dates inclusive) for the purpose of determining the entitlements
Registrar's name ,address, telephone no	Tricor Investor Services Sdn Bhd Level17, The Gardens North Tower Mid Valley City, Lingkaran Syed Putra 59200 Kuala Lumpur Telephone no.: 03-2264 3883
Payment date	07/11/2014
a.Securities transferred into the Depositor's Securities Account before 4:00 pm in respect of transfers	17/10/2014
b.Securities deposited into the Depositor's Securities Account before 12:30 pm in respect of securities exempted from mandatory deposit
c. Securities bought on the Exchange on a cum entitlement basis according to the Rules of the Exchange.
Number of new shares/securities issued (units) (If applicable)
Entitlement indicator	Currency
Currency	Malaysian Ringgit (MYR)
Entitlement in Currency	0.04